Not sure what that means but Gilead stock has been coming down the last few days. That make me wonder, are the institution anticipating a better solution soon and pulling away from GILD? Is the Wall Street Street smelling blood and getting ready to jump ship. Maybe when the pulling is done. Leronlimab will be approved? IMO. Maybe I am thinking too much, but GILD SP is coming down even with Rem labelled as SOC.